drugset / Trial / NCT04130204
Topical Application to Relieve Gout: Efficacy Trial & Safety (TARGETS)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This overall goal of this trial will be to demonstrate that DYV700 is safe and effective as a treatment for acute gout flares.
Timeline
- Start
- 2020-02-12
- Primary completion
- 2021-05-21
- Completion
- 2021-05-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DYV700 | Unknown | 10 ml | Topical |
| Background | Colchicine | Small molecule | 0.6 mg | — |